Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation
- PMID: 10229234
- DOI: 10.1038/8438
Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation
Abstract
Familial Alzheimer disease mutations of presenilin 1 (PS-1) enhance the generation of A beta1-42, indicating that PS-1 is involved in amyloidogenesis. However, PS-1 transgenic mice have failed to show amyloid plaques in their brains. Because PS-1 mutations facilitate apoptotic neuronal death in vitro, we did careful quantitative studies in PS-1 transgenic mice and found that neurodegeneration was significantly accelerated in mice older than 13 months (aged mice) with familial Alzheimer disease mutant PS-1, without amyloid plaque formation. However, there were significantly more neurons containing intracellularly deposited A beta42 in aged mutant transgenic mice. Our data indicate that the pathogenic role of the PS-1 mutation is upstream of the amyloid cascade.
Similar articles
-
Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.Exp Neurol. 2001 Aug;170(2):227-43. doi: 10.1006/exnr.2001.7710. Exp Neurol. 2001. PMID: 11476589
-
Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.J Neurochem. 2006 Mar;96(5):1322-35. doi: 10.1111/j.1471-4159.2005.03647.x. J Neurochem. 2006. PMID: 16478525
-
Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1.Nature. 1996 Oct 24;383(6602):710-3. doi: 10.1038/383710a0. Nature. 1996. PMID: 8878479
-
[Significance of intracellular A beta in Alzheimer's disease].Nihon Shinkei Seishin Yakurigaku Zasshi. 2002 Oct;22(5):175-80. Nihon Shinkei Seishin Yakurigaku Zasshi. 2002. PMID: 12451689 Review. Japanese.
-
Presenilin mutations in Alzheimer's disease.Hum Mutat. 1998;11(3):183-90. doi: 10.1002/(SICI)1098-1004(1998)11:3<183::AID-HUMU1>3.0.CO;2-J. Hum Mutat. 1998. PMID: 9521418 Review.
Cited by
-
Rodent Models of Amyloid-Beta Feature of Alzheimer's Disease: Development and Potential Treatment Implications.Aging Dis. 2020 Oct 1;11(5):1235-1259. doi: 10.14336/AD.2019.1026. eCollection 2020 Oct. Aging Dis. 2020. PMID: 33014535 Free PMC article. Review.
-
Targeting synaptic dysfunction in Alzheimer's disease therapy.Mol Neurobiol. 2012 Dec;46(3):572-87. doi: 10.1007/s12035-012-8324-3. Epub 2012 Aug 23. Mol Neurobiol. 2012. PMID: 22914888 Review.
-
Fighting the Cause of Alzheimer's and GNE Myopathy.Front Neurosci. 2018 Oct 15;12:669. doi: 10.3389/fnins.2018.00669. eCollection 2018. Front Neurosci. 2018. PMID: 30374284 Free PMC article. Review.
-
Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: a magnetic resonance microscopy and stereologic analysis.Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1381-6. doi: 10.1073/pnas.242746599. Epub 2003 Jan 24. Proc Natl Acad Sci U S A. 2003. PMID: 12552120 Free PMC article.
-
Fe3+ Facilitates Endocytic Internalization of Extracellular Aβ1-42 and Enhances Aβ1-42-Induced Caspase-3/Caspase-4 Activation and Neuronal Cell Death.Mol Neurobiol. 2019 Jul;56(7):4812-4819. doi: 10.1007/s12035-018-1408-y. Epub 2018 Nov 6. Mol Neurobiol. 2019. PMID: 30402707
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical